New York State Common Retirement Fund’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-74,700
| Closed | -$284K | – | 3357 |
|
|
2020
Q1 | $284K | Hold |
74,700
| – | – | ﹤0.01% | 2295 |
|
|
2019
Q4 | $380K | Sell |
74,700
-69,548
| -48% | -$354K | ﹤0.01% | 2434 |
|
|
2019
Q3 | $729K | Sell |
144,248
-643
| -0.4% | -$3.25K | ﹤0.01% | 2140 |
|
|
2019
Q2 | $894K | Sell |
144,891
-330
| -0.2% | -$2.04K | ﹤0.01% | 2074 |
|
|
2019
Q1 | $674K | Sell |
145,221
-34,517
| -19% | -$160K | ﹤0.01% | 2170 |
|
|
2018
Q4 | $755K | Buy |
179,738
+3,500
| +2% | +$14.7K | ﹤0.01% | 2068 |
|
|
2018
Q3 | $1.11M | Hold |
176,238
| – | – | ﹤0.01% | 2031 |
|
|
2018
Q2 | $1.42M | Sell |
176,238
-422
| -0.2% | -$3.39K | ﹤0.01% | 1897 |
|
|
2018
Q1 | $1.32M | Buy |
176,660
+24,979
| +16% | +$186K | ﹤0.01% | 1861 |
|
|
2017
Q4 | $903K | Sell |
151,681
-15,247
| -9% | -$90.8K | ﹤0.01% | 2093 |
|
|
2017
Q3 | $1.23M | Sell |
166,928
-72,597
| -30% | -$534K | ﹤0.01% | 1902 |
|
|
2017
Q2 | $1.63M | Buy |
239,525
+23,723
| +11% | +$161K | ﹤0.01% | 1808 |
|
|
2017
Q1 | $2.04M | Buy |
215,802
+6,772
| +3% | +$63.9K | ﹤0.01% | 1663 |
|
|
2016
Q4 | $1.81M | Hold |
209,030
| – | – | ﹤0.01% | 1752 |
|
|
2016
Q3 | $1.32M | Buy |
209,030
+57,490
| +38% | +$364K | ﹤0.01% | 1870 |
|
|
2016
Q2 | $639K | Hold |
151,540
| – | – | ﹤0.01% | 2175 |
|
|
2016
Q1 | $661K | Sell |
151,540
-264
| -0.2% | -$1.15K | ﹤0.01% | 2140 |
|
|
2015
Q4 | $931K | Buy |
151,804
+5,382
| +4% | +$33K | ﹤0.01% | 2021 |
|
|
2015
Q3 | $838K | Buy |
146,422
+30,634
| +26% | +$175K | ﹤0.01% | 2049 |
|
|
2015
Q2 | $864K | Buy |
115,788
+20,842
| +22% | +$156K | ﹤0.01% | 2261 |
|
|
2015
Q1 | $568K | Buy |
+94,946
| New | +$568K | ﹤0.01% | 2005 |
|